Assisted ventilation
08
Oct 2021
In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis), and two new Medtech Innovation Briefings (Carnation Ambulatory Monitor, OrganOx metra for liver transplant). Also, one clinical guideline was updated.
Read more
29
Sep 2021
In August 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (magnetic resonance therapy for knee osteoarthritis, laparoscopic removal of uterine fibroids with power morcellation, hysteroscopic mechanical tissue removal for uterine fibroids), and six new Medtech Innovation Briefings (PLASMA system with button electrode, Immunoscore, MMprofiler, Patient Status Engine, lung texture analysis, Colli-Pee). Also, five clinical guidelines were published.
Read more
29
Jun 2020
On June 23, 2020, the Swiss Federal Office of Public Health (FOPH) announced several changes in the coverage of benefits that will take place soon. They regard transcatheter aortic valve implantation (TAVI), adjustments in the List of Aids (EMAp/MiGeL) (including reimbursement for CPAP devices and mechanical ventilation at home, and adjustments in the List of Analyses (AL/EA).
Read more
05
May 2020
In April 2020, the National Institute for Health and Care Excellence (NICE) published only one new medical technologies guidance (for PneuX to prevent ventilator-associated pneumonia) and two Medtech innovation briefings (for Lifelight First for monitoring vital signs and myCOPD for self-management of chronic obstructive pulmonary disease).
Read more
02
Apr 2020
The report presents a summary of the reimbursement situation for mechanical ventilation in Europe. The following clinical indications are considered: acute community-acquired viral pneumonia complicated with acute respiratory failure; severe sepsis due to acute community-acquired viral pneumonia with multiorgan failure (cardiac, respiratory and renal); acute hemorrhagic stroke with the development of com. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Read more